These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 9794372)

  • 21. Mature mainstream TCR alpha beta+CD4+ thymocytes expressing L-selectin mediate "active tolerance" in the nonobese diabetic mouse.
    Herbelin A; Gombert JM; Lepault F; Bach JF; Chatenoud L
    J Immunol; 1998 Sep; 161(5):2620-8. PubMed ID: 9725264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RIP-beta 2-microglobulin transgene expression restores insulitis, but not diabetes, in beta 2-microglobulin null nonobese diabetic mice.
    Kay TW; Parker JL; Stephens LA; Thomas HE; Allison J
    J Immunol; 1996 Oct; 157(8):3688-93. PubMed ID: 8871671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post-thymic selection of peripheral CD4+ T-lymphocytes on class II major histocompatibility antigen-bearing cells.
    Shen X; König R
    Cell Mol Biol (Noisy-le-grand); 2001 Feb; 47(1):87-96. PubMed ID: 11292263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positive and negative selection of functional mouse CD4 cells by porcine MHC in pig thymus grafts.
    Zhao Y; Sergio JJ; Swenson K; Arn JS; Sachs DH; Sykes M
    J Immunol; 1997 Sep; 159(5):2100-7. PubMed ID: 9278295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T cell vaccination against autoimmune diabetes in nonobese diabetic mice.
    Formby B; Shao T
    Ann Clin Lab Sci; 1993; 23(2):137-47. PubMed ID: 8096128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In the normal repertoire of CD4+ T cells, a single class II MHC/peptide complex positively selects TCRs with various antigen specificities.
    Chmielowski B; Muranski P; Ignatowicz L
    J Immunol; 1999 Jan; 162(1):95-105. PubMed ID: 9886374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two mechanisms for the non-MHC-linked resistance to spontaneous autoimmunity.
    Verdaguer J; Amrani A; Anderson B; Schmidt D; Santamaria P
    J Immunol; 1999 Apr; 162(8):4614-26. PubMed ID: 10202001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes.
    Reich EP; Sherwin RS; Kanagawa O; Janeway CA
    Nature; 1989 Sep; 341(6240):326-8. PubMed ID: 2507922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-beta1.
    Moritani M; Yoshimoto K; Wong SF; Tanaka C; Yamaoka T; Sano T; Komagata Y; Miyazaki J; Kikutani H; Itakura M
    J Clin Invest; 1998 Aug; 102(3):499-506. PubMed ID: 9691086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of autoreactive diabetogenic T cells in the thymus of NOD mice.
    Kwon H; Jun HS; Yang Y; Mora C; Mariathasan S; Ohashi PS; Flavell RA; Yoon JW
    J Autoimmun; 2005 Feb; 24(1):11-23. PubMed ID: 15725572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isotypic residues in the membrane proximal domain of MHC class II beta-chains control activation of CD4+ T cells.
    Sant AJ
    J Immunol; 1993 Jun; 150(12):5299-310. PubMed ID: 8099935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mixed-haplotype MHC class II molecules select functional CD4+ T cells.
    Silk JD; Schoendorf D; Bartok I; Chai JG; Gray D; Simpson E; Dyson J
    Mol Immunol; 2005 Jun; 42(10):1129-39. PubMed ID: 15829303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maturation and function of mouse T-cells with a transgenic TCR positively selected by highly disparate xenogeneic porcine MHC.
    Zhao Y; Rodriguez-Barbosa JI; Zhao G; Shaffer J; Arn JS; Sykes M
    Cell Mol Biol (Noisy-le-grand); 2001 Feb; 47(1):217-28. PubMed ID: 11292257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The level of CD4 surface protein influences T cell selection in the thymus.
    Frank GD; Parnes JR
    J Immunol; 1998 Jan; 160(2):634-42. PubMed ID: 9551897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protection against diabetes by MHC heterozygosity and reversal by cyclophosphamide.
    Wu AY; Schulman SJ; Marconi LA; Reilly CR; Scott B; Lo D
    Cell Immunol; 1998 Mar; 184(2):112-20. PubMed ID: 9630837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T-cell receptor transgenic (TCR-Tg) mice from two diabetogenic CD4+ islet-antigen-specific T-cell clones.
    Haskins K
    J Autoimmun; 2004 Mar; 22(2):107-9. PubMed ID: 14987737
    [No Abstract]   [Full Text] [Related]  

  • 37. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
    Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
    Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Normal thymic selection of TCR transgenic CD4 T cells, but impaired survival in the periphery despite the presence of selecting MHC molecules.
    Barthlott T; Wright RJ; Stockinger B
    J Immunol; 1998 Oct; 161(8):3992-9. PubMed ID: 9780168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thymocyte antigens do not induce tolerance in the CD4+ T cell compartment.
    Jhaver KG; Chandler P; Simpson E; Mellor AL
    J Immunol; 1999 Nov; 163(9):4851-8. PubMed ID: 10528186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversal of type 1 diabetes by a new MHC II-peptide chimera: "Single-epitope-mediated suppression" to stabilize a polyclonal autoimmune T-cell process.
    Lin M; Stoica-Nazarov C; Surls J; Kehl M; Bona C; Olsen C; Brumeanu TD; Casares S
    Eur J Immunol; 2010 Aug; 40(8):2277-88. PubMed ID: 20540111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.